Inner Mongolia Furui Medical Science Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000KG1
CNY
57.71
1.76 (3.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
360.14
494.34
387.63
383.01
330.40
369.15
337.23
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
360.14
494.34
387.63
383.01
330.40
369.15
337.23
Raw Material Cost
90.42
153.74
122.69
117.64
94.71
140.20
99.31
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.91
0.97
0.79
0.82
0.65
0.90
0.62
Selling and Distribution Expenses
166.46
170.68
136.92
162.46
148.13
116.12
154.86
Other Expenses
3.06
1.61
1.75
2.28
1.74
2.57
2.20
Total Expenditure (Excl Depreciation)
288.41
341.53
277.93
303.70
260.83
282.97
276.80
Operating Profit (PBDIT) excl Other Income
71.7
152.79999999999998
109.7
79.3
69.6
86.19999999999999
60.4
Other Income
7.61
-7.93
1.28
-14.04
-6.59
4.37
5.23
Operating Profit (PBDIT)
76.48
159.80
137.34
86.20
86.68
102.94
89.57
Interest
0.91
0.97
0.79
0.82
0.65
0.90
0.62
Exceptional Items
0.00
-1.52
1.22
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
269.72
340.60
264.94
265.37
235.69
228.95
237.92
Depreciation
0.00
26.78
26.78
25.64
25.64
24.05
24.05
Profit Before Tax
75.57
130.54
110.99
59.74
60.40
77.99
64.91
Tax
20.96
30.32
25.37
18.01
18.44
22.94
16.45
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
31.79
42.20
59.95
23.30
28.64
11.28
26.64
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
31.79
42.20
59.95
23.30
28.64
11.28
26.64
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
20.33
54.22
24.09
12.98
13.04
25.44
20.77
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
52.12
96.42
84.04
36.28
41.68
36.73
47.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,981.80
1,978.32
1,905.44
1,824.94
1,781.97
1,747.68
1,602.84
Earnings per share (EPS)
0.12
0.16
0.23
0.09
0.11
0.04
0.1
Diluted Earnings per share
0.12
0.16
0.23
0.09
0.11
0.04
0.1
Operating Profit Margin (Excl OI)
19.12%
28.51%
28.19%
19.48%
20.47%
20.19%
17.88%
Gross Profit Margin
20.98%
31.82%
35.54%
22.29%
26.04%
27.64%
26.38%
PAT Margin
8.83%
8.54%
15.47%
6.08%
8.67%
3.06%
7.9%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 8.99% vs 3.02% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 24.94% vs -36.24% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -26.15% vs -9.15% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 50.00% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Inner Mongolia Furui Medical Science Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
360.14
0
360.14
Other Operating Income
0.00
0.00
0.00
Total Operating income
360.14
0
360.14
Raw Material Cost
90.42
0
90.42
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.91
0
0.91
Selling and Distribution Expenses
166.46
0
166.46
Other Expenses
3.06
0.00
3.06
Total Expenditure (Excl Depreciation)
288.41
0
288.41
Operating Profit (PBDIT) excl Other Income
71.73
0.00
71.73
Other Income
7.61
0
7.61
Operating Profit (PBDIT)
76.48
0
76.48
Interest
0.91
0
0.91
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
269.72
0
269.72
Depreciation
0.00
0
0.00
Profit Before Tax
75.57
0
75.57
Tax
20.96
0
20.96
Provisions and contingencies
0
0
0.00
Profit After Tax
31.79
0
31.79
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
31.79
0
31.79
Share in Profit of Associates
0
0
0.00
Minority Interest
20.33
0
20.33
Other related items
0.00
0.00
0.00
Consolidated Net Profit
52.12
0
52.12
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,981.80
0
1,981.80
Earnings per share (EPS)
0.12
0
0.12
Diluted Earnings per share
0.12
0
0.12
Operating Profit Margin (Excl OI)
19.12%
0%
0.00
19.12%
Gross Profit Margin
20.98%
0%
0.00
20.98%
PAT Margin
8.83%
0%
0.00
8.83%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 36.01 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -27.15% vs 27.53% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 8.99% vs 3.02% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.21 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -45.95% vs 14.76% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 24.94% vs -36.24% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.89 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -58.91% vs 23.22% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -26.15% vs -9.15% in Mar 2025

Quarterly - Interest
Interest 0.09 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -10.00% vs 25.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 50.00% vs 0.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.12%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025